Your browser doesn't support javascript.
loading
Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study.
Cuneo, Antonio; Follows, George; Rigolin, Gian Matteo; Piciocchi, Alfonso; Tedeschi, Alessandra; Trentin, Livio; Perez, Angeles Medina; Coscia, Marta; Laurenti, Luca; Musuraca, Gerardo; Farina, Lucia; Delgado, Alfredo Rivas; Orlandi, Ester Maria; Galieni, Piero; Mauro, Francesca Romana; Visco, Carlo; Amendola, Angela; Billio, Atto; Marasca, Roberto; Chiarenza, Annalisa; Meneghini, Vittorio; Ilariucci, Fiorella; Marchetti, Monia; Molica, Stefano; Re, Francesca; Gaidano, Gianluca; Gonzalez, Marcos; Forconi, Francesco; Ciolli, Stefania; Cortelezzi, Agostino; Montillo, Marco; Smolej, Lukas; Schuh, Anna; Eyre, Toby A; Kennedy, Ben; Bowles, Kris M; Vignetti, Marco; de la Serna, Javier; Moreno, Carol; Foà, Robin; Ghia, Paolo.
  • Cuneo A; Hematology, Department of Medical Sciences, St. Anna University Hospital, Ferrara, Italy cut@unife.it.
  • Follows G; UK CLL Forum, Cambridge University Hospitals NHS Foundation Trust, UK.
  • Rigolin GM; Hematology, Department of Medical Sciences, St. Anna University Hospital, Ferrara, Italy.
  • Piciocchi A; Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy.
  • Tedeschi A; Hematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Trentin L; Hematology and Clinical Immunology, Department of Medicine, University of Padua, Italy.
  • Perez AM; Hospital Costa del Sol, Marbella, Málaga, Spain.
  • Coscia M; Hematology Unit, Città della Salute e della Scienza, University of Turin, Italy.
  • Laurenti L; Hematology, Università Cattolica del Sacro Cuore, Policlinico A. Gemelli, Rome, Italy.
  • Musuraca G; Hematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Farina L; Hematology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy.
  • Delgado AR; Department of Hematology, Hospital Clinic, Institut Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Orlandi EM; Hematology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Galieni P; Hematology and Cellular Therapy, "Ospedale C. e G. Mazzoni", Ascoli Piceno, Italy.
  • Mauro FR; Hematology, Department of Biomedical Sciences and Hematology, "Sapienza" University, Rome, Italy.
  • Visco C; Hematology, San Bortolo Hospital, Vicenza, Italy.
  • Amendola A; Hematology, San Carlo Hospital, Potenza, Italy.
  • Billio A; Hematology and Transplant Unit, San Maurizio Hospital, Azienda Sanitaria dell'Alto Adige, Bolzano, Italy.
  • Marasca R; Hematology Unit, University Hospital, Modena, Italy.
  • Chiarenza A; Hematology Unit, Azienda Universitaria Ospedaliera Policlinico Vittorio Emanuele, Catania, Italy.
  • Meneghini V; Hematology, Department of Cell Therapy and Hematology, University Hospital, Verona, Italy.
  • Ilariucci F; Hematology Unit, Arcispedale S. Maria Nuova, Reggio Emilia, Italy.
  • Marchetti M; Oncology Unit, Cardinal Massaia Hospital, Asti, Italy.
  • Molica S; Hematology Unit, A. Pugliese Hospital, Azienda Ospedaliera Pugliese Ciaccio, Catanzaro, Italy.
  • Re F; Hematology, University Hospital, Parma, Italy.
  • Gaidano G; Hematology, DIMECS e Dipartimento Oncologico, Università del Piemonte Orientale Amedeo Avogadro, Novara, Italy.
  • Gonzalez M; Hematology, University Hospital-IBSAL and CIBERONC, Salamanca, Spain.
  • Forconi F; Haematology Department, University Hospital National Health Service Trust, Southampton, UK.
  • Ciolli S; Hematology Unit, Careggi Hospital, Florence, Italy.
  • Cortelezzi A; Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Italy.
  • Montillo M; Hematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Smolej L; Department of Hematology, University Hospital, Hradec Kralove, Czech Republic.
  • Schuh A; UK CLL Forum, Oxford University Hospitals NHS Foundation Trust, UK.
  • Eyre TA; Oxford University Hospitals NHS Foundation Trust, UK.
  • Kennedy B; University Hospitals of Leicester NHS Trust, UK.
  • Bowles KM; Norwich Medical School, UK.
  • Vignetti M; Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy.
  • de la Serna J; Hematology Unit, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Moreno C; Hospital de la Santa Creu i Sant Pau, Barcellona, Spain.
  • Foà R; Hematology, Department of Biomedical Sciences and Hematology, "Sapienza" University, Rome, Italy.
  • Ghia P; Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute and Vita-Salute San Raffaele University, Milan, Italy.
Haematologica ; 103(7): 1209-1217, 2018 07.
Article en En | MEDLINE | ID: mdl-29674504
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirazoles / Pirimidinas / Leucemia Linfocítica Crónica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Humans / Middle aged País como asunto: Europa Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirazoles / Pirimidinas / Leucemia Linfocítica Crónica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Humans / Middle aged País como asunto: Europa Idioma: En Año: 2018 Tipo del documento: Article